FindMyKOL
Clinical trialNCT03168906TerminatedPhase 2Interventional

Renal AL Amyloid Involvement and NEOD001

SponsorTufts Medical CenterEnrollment12Amyloidosis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a multicenter, Phase 2b, randomized, double-blind, placebo-controlled, two-arm, parallel-group efficacy and safety study of NEOD001 as a single agent administered intravenously in adults with AL amyloidosis who have a maintained hematologic response to their most recent treatment for AL amyloidosis (e.g., chemotherapy, autologous stem cell transplant \[ASCT\]) and have persistent renal dysfunction.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Mayo Clinic- Arizona

    Scottsdale, Arizona, United States

  • University of California San Francisco

    San Francisco, California, United States

  • Mayo Clinic- Florida

    Jacksonville, Florida, United States

  • Tufts Medical Center

    Boston, Massachusetts, United States

  • Karmanos Cancer Institute

    Detroit, Michigan, United States

  • Mayo Clinic- Minnesota

    Rochester, Minnesota, United States

  • Memorial Sloan-Kettering Cancer Center

    New York, New York, United States

  • Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

NEOD001Placebo
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
5 Jul 2017
Primary completion
23 Apr 2018
Completion
6 Feb 2019
Last update posted
9 Sept 2020
Registered enrollment
12
Registry id
NCT03168906
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.